Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Cardiol J ; 2023 Apr 17.
Article in English | MEDLINE | ID: mdl-37067334

ABSTRACT

BACKGROUND: It has been suggested that patients with myocardial infarction and non-obstructive coronary arteries (MINOCA) have more psycho-emotional disorders than patients with obstructive coronary artery disease (MICAD). The aim of this study is to compare the prevalence of anxiety, insomnia, and type D personality between MINOCA and MICAD and their impact on prognosis. METHODS: Patients with myocardial infarction undergoing coronary angiography were prospectively enrolled. Psychological questionnaires were completed by each patient during admission. RESULTS: Among a total of 533 patients, 56 had MINOCA and 477 had MICAD. There were no differences in the prevalence of anxiety and insomnia between both groups: trait anxiety median value (M) MINOCA = 18 (11-34) vs. MICAD M = 19 (12-27), p = 0.8; state anxiety MINOCA M = 19 (11-29) vs. MICAD M = 19 (12.2-26), p = 0.6; and insomnia MINOCA M = 7 (3-11) vs. MICAD M = 7 (3-12), p = 0.95. More MINOCA patients had type D personality (45.0% vs. 28.5%, p = 0.03). At 3-year follow-up, there were no differences in mortality between MINOCA and MICAD (hazard ratio [HR] 0.78, 95% confidence interval [CI] 0.28-2.17) in major adverse cerebral or cardiovascular events (MACCE) (HR 0.71, 95% CI 0.38-1.31). Scores of trait anxiety and negative affectivity were significantly associated with MACCE (HR 1.65, 95% CI [1.05-2.57]; HR 1.75, 95% CI [1.11-2.77], respectively). High insomnia levels were associated with greater mortality (HR 2.72, 95% CI [1.12-6.61]). CONCLUSIONS: Anxiety and insomnia levels were similar between patients with MINOCA and those with MICAD, whilst the prevalence of type D personality was higher in the MINOCA than in the MICAD group. Higher scores in trait anxiety, insomnia, and negative affectivity were related to a worse prognosis at 3-year follow-up.

2.
Cardiol J ; 29(2): 228-234, 2022.
Article in English | MEDLINE | ID: mdl-32329038

ABSTRACT

BACKGROUND: Anthracycline cardiotoxicity (AC) may manifest years after treatment (long-term cardiotoxicity). There is little data on the incidence and natural history of AC in the current context, with protocols including lower anthracycline doses. The present study prospectively evaluated the incidence, time of occurrence and clinical correlates of long-term cardiotoxicity and the evolution of systolic function in patients with breast cancer treated with anthracyclines. METHODS: This study prospectively included 85 consecutive patients undergoing chemotherapy (CHT) with anthracyclines without trastuzumab. All patients underwent evaluation at baseline, at the end of CHT, 3 months after the end of CHT and 1 and 4 years subsequent to the beginning of CHT. Clinical data and echocardiographic parameters were evaluated in all examinations. RESULTS: The mean dose of doxorubicin used was 243.53 mg/m2. Median follow-up of the current cohort was 4.5 years. At 1 year the incidence of AC was 1% and at the end of the follow-up 16.5% (14 of 85 patients). Therefore, the incidence of late cardiotoxicity (after the first year) was 15%. Of these 14 patients with AC, 12 had asymptomatic systolic dysfunction, 1 had heart failure and 1 suffered sudden death. Fifteen percent developed systolic dysfunction during follow-up. An early decline in strain was observed in patients who developed long-term AC. CONCLUSIONS: The incidence of long-term cardiotoxicity in patients treated with low-cumulative dose of anthracyclines is high, 16.5% at 4.5 years. This was observed in almost all cases after the first year of follow-up. Therefore, long-term monitoring may be advisable.


Subject(s)
Breast Neoplasms , Cardiomyopathies , Anthracyclines/adverse effects , Antibiotics, Antineoplastic/adverse effects , Breast Neoplasms/drug therapy , Cardiomyopathies/complications , Cardiotoxicity/drug therapy , Cardiotoxicity/epidemiology , Cardiotoxicity/etiology , Female , Humans , Incidence , Trastuzumab/adverse effects
3.
Med. clín (Ed. impr.) ; 151(10): 397-399, nov. 2018. tab
Article in Spanish | IBECS | ID: ibc-174027

ABSTRACT

Introducción y objetivos: La osteogénesis imperfecta (OI) es una enfermedad del tejido conectivo que se caracteriza por una síntesis anómala del colágeno tipo i. Se sabe poco sobre la afectación cardiovascular que presentan estos pacientes. Las descritas con más frecuencia son la disfunción valvular y la dilatación de la aorta. Hemos querido analizar los cambios estructurales y funcionales del corazón en pacientes adultos con OI. Métodos: Estudiamos prospectivamente 82 pacientes con OI y los comparamos con 60 sujetos sanos emparejados por edad y sexo. A todos se les realizó un estudio ecocardiográfico. Resultados: No encontramos diferencias en la incidencia de valvulopatías respecto al grupo control. Nuestros pacientes tenían un mayor tamaño de la aurícula izquierda y mayores diámetros del ventrículo izquierdo (VI) ajustados por superficie corporal. La raíz de la aorta era significativamente mayor. La fracción de eyección del VI en los pacientes con OI era menor y tenían una presión sistólica de la arteria pulmonar mayor. Conclusiones: Los pacientes con OI presentan cambios estructurales y funcionales en el corazón. Sería recomendable un seguimiento para ver la evolución de estos cambios


Introduction and objectives: Osteogenesis imperfecta (OI) is a connective tissue disease characterised by an anomalous synthesis of type i collagen. Little is known about the cardiovascular affectation suffered by these patients. The most frequently described are valvular dysfunction and dilatation of the aorta. We wanted to analyse the structural and functional changes of the heart in adult patients with OI. Methods: We prospectively studied 82 patients with OI and compared them with 60 healthy subjects matched for age and sex. All of them underwent an echocardiographic study. Results: We found no differences in the incidence of valvulopathies compared to the control group. Our patients had a larger left atrium and larger left ventricle (LV) diameters adjusted for body surface area. Aortic root was significantly higher. LV ejection fraction in patients with OI was lower and they had higher pulmonary artery systolic pressure. Conclusions: Patients with OI suffer structural and functional changes in the heart. A follow-up is recommended to observe the evolution of these changes


Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Adult , Middle Aged , Osteogenesis Imperfecta/complications , Heart/physiopathology , Collagen/metabolism , Heart Valve Diseases/epidemiology , Adult , Case Reports , Echocardiography/methods , Prospective Studies , Stroke Volume/physiology
4.
Med Clin (Barc) ; 151(10): 397-399, 2018 11 21.
Article in English, Spanish | MEDLINE | ID: mdl-29665967

ABSTRACT

INTRODUCTION AND OBJECTIVES: Osteogenesis imperfecta (OI) is a connective tissue disease characterised by an anomalous synthesis of type i collagen. Little is known about the cardiovascular affectation suffered by these patients. The most frequently described are valvular dysfunction and dilatation of the aorta. We wanted to analyse the structural and functional changes of the heart in adult patients with OI. METHODS: We prospectively studied 82 patients with OI and compared them with 60 healthy subjects matched for age and sex. All of them underwent an echocardiographic study. RESULTS: We found no differences in the incidence of valvulopathies compared to the control group. Our patients had a larger left atrium and larger left ventricle (LV) diameters adjusted for body surface area. Aortic root was significantly higher. LV ejection fraction in patients with OI was lower and they had higher pulmonary artery systolic pressure. CONCLUSIONS: Patients with OI suffer structural and functional changes in the heart. A follow-up is recommended to observe the evolution of these changes.


Subject(s)
Aorta/pathology , Hypertrophy, Left Ventricular/pathology , Myocardium/pathology , Osteogenesis Imperfecta/pathology , Adolescent , Adult , Aorta/diagnostic imaging , Body Surface Area , Case-Control Studies , Echocardiography , Female , Heart/diagnostic imaging , Humans , Hypertrophy, Left Ventricular/diagnostic imaging , Male , Osteogenesis Imperfecta/complications , Osteogenesis Imperfecta/physiopathology , Prospective Studies , Stroke Volume , Ventricular Function, Left , Young Adult
6.
Cardiol J ; 25(1): 24-31, 2018.
Article in English | MEDLINE | ID: mdl-29240964

ABSTRACT

BACKGROUND: There is an emerging field underlying the myocardial infarction (MI) with non-obstruc-tive coronary arteries (MINOCA). The aim of this study was to evaluate the impact of psycho-emotional disorders and social habits in MINOCA patients. METHODS: The study included 95 consecutive patients diagnosed of MINOCA and 178 patients with MI and obstructive lesions. MINOCA patients were included when they fulfilled the three main criteria: accomplishment of the Third Universal Definition of Myocardial Infarction, absence of obstructive coronary arteries and no clinically overt specific cause for the acute presentation. RESULTS: MINOCA patients had a higher frequency of previous psychiatric illnesses than the obstructive coronary arteries group (29.7% vs. 12.9%, p = 0.001). MINOCA patients recognized emotional stress in 75.7% of the cases, while only 32.1% of the obstructive related group did (p < 0.001). The relation-ship remained after excluding takotsubo syndrome from the analysis (26 cases, 27.4%): psychiatric diseases (27.9% vs. 12.9%, p < 0.01) and recognition of emotional stress (70.8% vs. 32.1%, p < 0.001). Social habits which could act as stress modulating showed no significant relation with MINOCA. CONCLUSIONS: Psycho-emotional disorders are related to MINOCA and they could act as risk fac-tor. This relationship is maintained after excluding takotsubo from the analysis. (Cardiol J 2018; 25, 1: 24-31).


Subject(s)
Coronary Artery Disease/complications , Coronary Vessels/diagnostic imaging , Mood Disorders/complications , Myocardial Infarction/etiology , Registries , Risk Assessment/methods , Aged , Coronary Angiography , Coronary Artery Disease/diagnosis , Female , Humans , Incidence , Male , Middle Aged , Mood Disorders/epidemiology , Mood Disorders/psychology , Myocardial Infarction/diagnosis , Myocardial Infarction/epidemiology , Risk Factors , Spain/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...